Alpha Tau Medical is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Uzi Sofer, with a market cap of $646.9M.
Common questions about Alpha Tau Medical
Alpha Tau Medical is scheduled to report earnings for Q1 2026 on May 18, 2026. Analysts estimate revenue of $115.8K.
Alpha Tau Medical has approximately 121 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.